Sunshine Biopharma Inc Ordinary Shares SBFM 深 沪
等待开盘 09-24 09:30:00 美东时间
1.58
+0.070
+4.64%
华盛通- 最 高1.6688
- 今 开1.51
- 成交量 18.68万股
- 最 低 1.495
- 昨 收 1.51
- 总市值 719.83万
- 52周最高 3.90
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.1693
- 委 比 -76.77%
- 总股本 455.59万
- 历史最高 19740.00
- 量 比 6.38
- 振 幅 11.51%
- 历史最低 1.1693
- 每 手 1
- 风险率 0.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sunshine Biopharma Filed U.S. Patent Application #20250276036 For "COMPOSITION FOR THE INHIBITION OF NRF2 AND USES THEREOF IN CANCER THERAPY"
https://ppubs.uspto.gov/api/pdf/downloadPdf/20250276036?requestToken=eyJzdWIiOiIyZDUxZWIxMy0xNzcwLTRmZDItYWZhYi1hZDZhM2MxMzVjOTQiLCJ2ZXIiOiIzYWZmYTM0My00ODdkLTQ4YTMtOWNmNy05NWFhM2IwOTYzZGMiLCJleHAiOjB9
09-05 04:00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
07-02 20:06
Sunshine Biopharma Announces That Its Wholly Owned Canadian Subsidiary, Nora Pharma, Has Launched Niopeg, The Company's First Biosimilar Drug
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
07-02 20:06
Sunshine Biopharma's Canadian Subsidiary, Nora Pharma, Launches Gabapentin, A New Generic Prescription Drug In The Therapeutic Class Of Anticonvulsants
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
06-11 20:56
Sunshine Biopharma reports Q1 results
Sunshine Biopharma press release (NASDAQ:SBFM): Q1 Revenue of $8.9M (+18.0% Y/Y). More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma Historical earnings data for Sunshine Bi...
05-16 16:05
Sunshine Biopharma Announces $2.46M Registered Direct Offering At $2.07 A Share
FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas
04-03 01:24
Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada
Sunshine Biopharma (NASDAQ:SBFM) Monday said that it has signed a strategic agreement granting it the rights to market two new generic antibiotics in Canada. The company anticipates launching these ne...
03-24 20:19
Sunshine Biopharma Appoints New Chief Commercial Officer
The latest announcement is out from Sunshine Biopharma ( ($SBFM) ). Sunshine Bi...
01-16 08:09
Sunshine Biopharma files $100M mixed securities shelf
Sunshine Biopharma (NASDAQ:SBFM) filed for $100M mixed securities shelf. This prospectus is not an offer to sell. Filing More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma H...
01-07 02:27
Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target
Aegis Capital analyst David Bouchey reiterates Sunshine Biopharma (NASDAQ:SBFM) with a Buy and maintains $15 price target.
2024-12-06 00:37
